Dr. Carlozzi’s research focuses on improving outcomes assessment through improvements in test sensitivity, efficiency and clinical utility. Her research portfolio includes two large-scale, multi-site studies funded by NIH (awards total ~$7,000,000), as well as several smaller awards from the NIH, the Department of Education, the CHDI foundation, a private donor, and the Michigan Alzheimer’s Disease Center. Dr. Carlozzi’s NIH awards, including two R01s, involve: 1) developing new computer adaptive tests, and 2) validating PROMIS and Neuro-QOL in clinical populations. Specifically, one project is focused on individuals with Huntington disease, while the other project targets caregivers of individuals with traumatic brain injury. In addition to these studies, she is an investigator for several projects providing HRQOL measurement analysis expertise, measurement selection and evaluation expertise, and/or HRQOL measurement development and validation expertise. Dr. Carlozzi received the prestigious Rosenthal Early Career Award from the American Psychological Association.